Irhythm Technologies Inc (IRTC)

Jun 5, 2025, 10:00 AM EDT - 1 day ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 3, 2025, 10:00 AM EDT - 3 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 5 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Investors to Inquire about Securities Investigation

May 29, 2025, 10:00 AM EDT - 8 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Reach Out

May 21, 2025, 4:45 PM EDT - 16 days ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

May 2, 2025, 1:24 PM EDT - 5 weeks ago

Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts

May 1, 2025, 9:14 PM EDT - 5 weeks ago

iRhythm Technologies, Inc. (IRTC) Q1 2025 Earnings Call Transcript

May 1, 2025, 4:10 PM EDT - 5 weeks ago

iRhythm Launches Zio® Long-Term Continuous Monitoring Service in Japan as the Zio® ECG Recording and Analysis System, Advancing AI-Powered Arrhythmia Detection

Apr 29, 2025, 6:05 PM EDT - 5 weeks ago

iRhythm Technologies to Present at the Bank of America Securities 2025 Health Care Conference

Apr 28, 2025, 8:05 AM EDT - 5 weeks ago

iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring

Apr 17, 2025, 4:30 PM EDT - 7 weeks ago

iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 16, 2025, 8:35 AM EDT - 7 weeks ago

iRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and Sustainability

Mar 31, 2025, 8:05 AM EDT - 2 months ago

iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection

Feb 21, 2025, 12:23 AM EST - 3 months ago

iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:05 PM EST - 3 months ago

iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 14, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Feb 13, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out

Feb 12, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation

Feb 11, 2025, 10:00 AM EST - 4 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 10, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation

Feb 9, 2025, 10:00 AM EST - 4 months ago

iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 7, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect

Feb 6, 2025, 4:05 PM EST - 4 months ago

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Feb 6, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation

Feb 4, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect

Jan 14, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation

Jan 13, 2025, 8:30 AM EST - 5 months ago

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Reach Out

Dec 30, 2024, 4:30 PM EST - 5 months ago

iRhythm Technologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 20, 2024, 4:30 PM EST - 7 months ago

iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference

Nov 18, 2024, 8:15 AM EST - 7 months ago

iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring

Nov 5, 2024, 4:30 PM EST - 7 months ago

iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference

Oct 30, 2024, 8:26 PM EDT - 7 months ago

iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 5:15 PM EDT - 7 months ago

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device

Oct 30, 2024, 4:08 PM EDT - 7 months ago

iRhythm Technologies Announces Third Quarter 2024 Financial Results

Oct 28, 2024, 8:02 AM EDT - 7 months ago

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy

Oct 22, 2024, 1:18 PM EDT - 8 months ago

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says

Oct 21, 2024, 4:05 PM EDT - 8 months ago

iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device

Oct 16, 2024, 4:05 PM EDT - 8 months ago

iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024

Sep 20, 2024, 8:00 AM EDT - 9 months ago

Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm

Sep 11, 2024, 8:05 AM EDT - 9 months ago

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence

Sep 9, 2024, 8:05 AM EDT - 9 months ago

iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting

Sep 1, 2024, 1:33 PM EDT - 9 months ago

iRhythm Technologies Announces Results of GUARD-AF Trial

Aug 29, 2024, 8:00 AM EDT - 10 months ago

iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain

Aug 21, 2024, 4:05 PM EDT - 10 months ago

iRhythm Technologies to Participate in Upcoming Investor Conferences in September

Aug 2, 2024, 8:06 AM EDT - 11 months ago

iRhythm Technologies, Inc. (IRTC) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:06 PM EDT - 11 months ago

iRhythm Technologies Announces Chief Financial Officer Transition

Jul 18, 2024, 4:05 PM EDT - 11 months ago

iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024

Jun 20, 2024, 9:13 AM EDT - 1 year ago

This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

SWKS BFH OCUL TRU